Klaus Dugi

Klaus Dugi currently serves as the Chief Executive Officer at Vandria since October 2021 and holds dual roles as Venture Partner and Chief Medical Advisor at NanoDimension since January 2021. Additionally, Klaus Dugi is a Non Executive Director at AOBiome Therapeutics, Inc. since August 2018. From October 2017 to December 2020, Klaus Dugi worked as Executive Vice President and Chief Medical Officer at Ferring Pharmaceuticals, where responsibilities included Medical Affairs, Pharmacovigilance, and Quality Assurance as a member of the Executive Board. Previous roles include Managing Director for Boehringer Ingelheim Limited UK from August 2015 to September 2017 and various positions at Boehringer Ingelheim from July 2006 to July 2015, including Chief Medical Officer and Corporate Vice President of Medical Affairs. Klaus Dugi started the medical career as an Attending Physician at Med. Univ.Klinik. Heidelberg from 2001 to 2002.